Good Clinical Practice

Good Clinical Practice
Name	Good Clinical Practice
Abbreviation	GCP
Discipline	Clinical research
Originated	International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use
First implemented	1996
Related	Declaration of Helsinki, Nuremberg Code, Belmont Report

Good Clinical Practice Good Clinical Practice is an international ethical and scientific quality standard for designing, conducting, recording, and reporting clinical trials that involve human subjects. It aligns requirements from the World Health Organization, the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use, and regional authorities such as the United States Food and Drug Administration, the European Medicines Agency, and the Medicines and Healthcare products Regulatory Agency. The standard reflects foundational documents including the Nuremberg Code, the Declaration of Helsinki, and the Belmont Report, and interfaces with national statutes like the Federal Food, Drug, and Cosmetic Act and directives such as the Clinical Trials Directive (EU).

Overview

GCP codifies responsibilities for sponsors, investigators, and monitors within an ethical and scientific framework influenced by landmark events such as the Tuskegee Syphilis Study, the Thalidomide tragedy, and regulatory responses exemplified by the Kefauver Harris Amendment. It provides harmonized criteria for trial conduct across jurisdictions including Japan, Canada, Australia, and member states of the European Union, ensuring that data submitted to authorities such as the European Commission and the United States Department of Health and Human Services are reliable and that participant rights are protected. Major implementing documents include ICH E6 and guidance from the Council for International Organizations of Medical Sciences.

Principles and Ethics

The ethical principles underlying GCP derive from documents like the Declaration of Helsinki, the Nuremberg Code, and reports such as the Belmont Report, emphasizing respect for persons, beneficence, and justice as applied in trials overseen by institutions such as the National Institutes of Health and hospital review bodies like Johns Hopkins Hospital Institutional Review Boards. Informed consent processes must meet standards cited by legal decisions in courts such as the United States Supreme Court and be compatible with policies from agencies like the European Court of Human Rights and national ethics committees in countries including Germany and France. Conflicts of interest are managed per frameworks used by institutions like Harvard University, the Wellcome Trust, and regulatory offices such as the Office for Human Research Protections.

Regulatory Framework and Guidelines

GCP is implemented through documents including ICH E6 and regional regulations such as the European Medicines Agency's guidelines, the United States Food and Drug Administration regulations in 21 CFR, and national laws like the Medicines Act in the United Kingdom and the Pharmaceutical Affairs Law in Japan. International oversight bodies such as the World Health Organization and nongovernmental organizations like the Council for International Organizations of Medical Sciences provide guidance harmonized with standards from the International Conference on Harmonisation and enforcement by agencies like the Federal Trade Commission in specific contexts. Clinical trial registration expectations link to platforms and policies from entities including the World Health Organization International Clinical Trials Registry Platform, the European Clinical Trials Database, and national registries such as ClinicalTrials.gov.

Roles and Responsibilities

Sponsors, investigators, monitors, and ethics committees operate under role definitions influenced by institutions such as the Pharmaceutical Research and Manufacturers of America, the Association of the British Pharmaceutical Industry, and academic centers including Stanford University School of Medicine and the University of Oxford. Institutional Review Boards or Research Ethics Committees similar to those at Massachusetts General Hospital and the Karolinska Institute review protocols, while regulatory inspections are conducted by agencies such as the United States Food and Drug Administration and the European Medicines Agency. Contract Research Organizations like Covance and PPD support sponsors, and data management partners liaise with entities such as the Clinical Data Interchange Standards Consortium.

Clinical Trial Processes

Protocol development, informed consent, investigator selection, monitoring, and reporting of adverse events follow procedures exemplified in pivotal trials at institutions like Mayo Clinic and corporate studies by companies such as Pfizer and Roche. Statistical analysis plans reference standards promoted by organizations including the International Society for Clinical Biostatistics and trial registration requirements from platforms like ClinicalTrials.gov and the European Clinical Trials Database. Safety reporting pathways interact with pharmacovigilance systems run by the European Medicines Agency and the United States Food and Drug Administration's Adverse Event Reporting System.

Quality Assurance and Compliance

Auditing, inspection readiness, and corrective action/preventive action programs reflect best practices used by sponsors such as Johnson & Johnson and by regulatory agencies like the Medicines and Healthcare products Regulatory Agency. Compliance management draws on standards from bodies including the International Organization for Standardization and enforcement mechanisms applied in cases adjudicated by courts such as the United States Court of Appeals and administrative actions by the European Commission. Electronic record standards reference guidance from the United States Food and Drug Administration and committees like the Pharmaceutical Inspection Co-operation Scheme.

Training and Certification

Training frameworks for investigators, study coordinators, and monitors are provided by professional organizations including the Society of Clinical Research Associates, the Association of Clinical Research Professionals, and academic programs at institutions like Duke University School of Medicine and Imperial College London. Certification and continuing education are offered by bodies such as the Regulatory Affairs Professionals Society, and online curricula often align with guidance from the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use and the World Health Organization.

Category:Clinical research